Prolonged weakness after the withdrawal of atracurium

American Journal of Respiratory and Critical Care Medicine

Volumn 150, Issue 5 I, 1994, Pages 1441-1443

  Manthous, Constantine A ^a   Chatila, Wissam ^b   Talbot, Kathleen ^b  

^a BRIDGEPORT HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; CREATINE KINASE;

ADULT; ARTICLE; ASTHMATIC STATE; CASE REPORT; DOSE TIME EFFECT RELATION; DRUG METABOLISM; FEMALE; HUMAN; MUSCLE WEAKNESS; NEUROMUSCULAR BLOCKING; PARESIS; PRIORITY JOURNAL;

EID: 85041136929     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.150.5.7952572     Document Type: Article

References (21)

1. Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992;327:524-8.
2. Shapiro JM, Condos R, Cole RP. Myopathy of status asthmaticus: relation to neuromuscular blockade and corticosteroid administration. J Intensive Care Med 1993;8:144-52.
3. Hansen-Flaschen J, Cowen J, Raps EC. Neuromuscular blockade in the intensive care unit. More than we bargained for. Am Rev Respir Dis 1993;147:234-6.
4. Kupfer Y, Namba T, Kaldawi E, Tessler S. Prolonged weakness after long-term infusion of vecuronium. Ann Intern Med 1992;117:484-6.
5. Gooch JL, Suchyta MR, Balbierz JM, Petajan JH, Clemmer TP. Prolonged paralysis after treatment with neuromuscular blocking drugs Crit Care Med 1991;19:1125-31.
6. Subramony SH, Carpenter DE, Raju S, Pride M, Evans O. Myopathy and prolonged neuromuscular blockade after lung transplant. Crit Care Med 1991;19:1580-2.
7. Danon MJ, Carpenter S. Myopathy with thick filament loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991;14:1131-9.
8. Hirano M, Ott B, Raps E, et al. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992;42:2082-7.
9. Torres CF, Maniscalco WM. Muscle weakness and atrophy following prolonged paralysis with pancuronium bromide in neonates. Ann Neurol 1985;18:403.
10. Rossiter M, Souney PF, McGowan S, Carvajal P. Pancuronium-induced prolonged neuromuscular blockade. Crit Care Med 1991;19:1583-7.
11. Griffin D, Fairman N, Coursin D, Rawsthorne L, Grossman JE. Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest 1992;102:510-4.
12. Yate PM, Flynn PJ, Arnold RW, Weatherly BC, Simmonds RJ, Dopson T. Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit. Br J Anaesth 1987;59:211-7.
13. Griffiths RB, Hunter JM, Jones RS. Atracurium infusions in patients with renal failure on an ITU. Anaesthesia 1986;41:375-81.
14. Douglass JA, Tuxen DV, Horne M, Scheinkestel CD, Weinmann M, Czarnyu D, Bowes G. Myopathy in severe asthma. Am Rev Respir Dis 1992;146:517-9.
15. Williams TJ, O'Hehir RE, Czarny D, Horne M, Bowes G. Acute myopathy in severe acute asthma treated with intravenously administered corticosteroids. Am Rev Respir Dis 1988;137:460-3.
16. Toft P, Helbo-Hansen S. Interaction of ketamine with atracurium. Br J Anaesth 1989;62:319-20.
17. Vianna IG, Doulouris N, Lanigan C, Moxham J. Effect of acute hypercapnia on limb muscle contractility in humans. J Appl Physiol 1990; 69: 1486-93.
18. Juan G, Calverley P, Talamo C, Schnader J, Roussos C. Effect of carbon dioxide on diaphragmatic function in human beings. N Engl J Med 1984;310:874-9.
19. Coakley JH, Nagendran K, Hanavar M, Hinds CJ. Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med 1993;19:323-8.
20. Zochodne DW, Bolton CF, Walls GA, et al. Critical illness polyneuropathy. Brain 1987;110:822-43.
21. Meyer KC, Prielipp RC, Grossman JE, Coursin DB. Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 1994;78:772-4.